# Rethinking Human Energy Metabolism

**Authors:** Alexander Panov, Vladimir Mayorov, Sergey Dikalov, Alexandra Krasilnikova, Lev Yaguzhinsky

PMC · DOI: 10.3390/cimb48020159 · Current Issues in Molecular Biology · 2026-02-01

## TL;DR

This paper reviews how glycolysis and mitochondrial processes work together, with lactate playing a key role in energy metabolism.

## Contribution

The paper proposes that fatty acid β-oxidation and glycolysis form an interdependent energy metabolism system in humans.

## Key findings

- Obligate lactate formation during glycolysis enhances the TCA cycle's anaplerotic functions.
- Fatty acid β-oxidation is essential for lactate production, which supports mitochondrial respiration.
- Lactate acts as an emergency energy substrate for the heart, muscles, and brain.

## Abstract

For a long time, glycolysis and mitochondrial oxidative phosphorylation were opposed to each other. Glycolysis works when there is a lack of oxygen; the mitochondria supply ATP in an oxygen environment. In recent decades, it has been discovered that glycolysis in vivo always works and the final product is lactate. Lactate can accumulate and is the transport form for pyruvate. In this review, we look at how obligate lactate formation during glycolysis affects the tricarboxylic acid (TCA) cycle and mitochondrial respiration. We conclude that fatty acid β-oxidation is a prerequisite for obligate lactate formation during glycolysis, which in turn promotes and enhances the anaplerotic functions of the TCA cycle. In this way, a supply of two types of substrates for mitochondria is formed: fatty acids as the basic energy substrates, and lactate as an emergency substrate for the heart, skeletal muscles, and brain. High steady-state levels of lactate and ATP, supported by β-oxidation, stimulate gluconeogenesis and thus support the lactate cycle. It is concluded that mitochondrial fatty acids β-oxidation and glycolysis constitute a single interdependent system of energy metabolism of the human body.

## Linked entities

- **Chemicals:** lactate (PubChem CID 61503), pyruvate (PubChem CID 107735)

## Full-text entities

- **Genes:** ME2 (malic enzyme 2) [NCBI Gene 4200] {aka ODS1}, ACADL (acyl-CoA dehydrogenase long chain) [NCBI Gene 33] {aka ACAD4, LCAD}, ACADM (acyl-CoA dehydrogenase medium chain) [NCBI Gene 34] {aka ACAD1, MCAD, MCADH}, TEAD2 (TEA domain transcription factor 2) [NCBI Gene 8463] {aka ETF, TEAD-2, TEF-4, TEF4}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, CYC1 (cytochrome c1) [NCBI Gene 1537] {aka MC3DN6, UQCR4}, SLC25A6 (solute carrier family 25 member 6) [NCBI Gene 293] {aka AAC3, ANT, ANT 2, ANT 3, ANT3, ANT3Y}, GLYAT (glycine-N-acyltransferase) [NCBI Gene 10249] {aka ACGNAT, GAT}, ACADVL (acyl-CoA dehydrogenase very long chain) [NCBI Gene 37] {aka ACAD6, LCACD, VLCAD}, SDHB (succinate dehydrogenase complex iron sulfur subunit B) [NCBI Gene 6390] {aka CWS2, IP, MC2DN4, PGL4, PPGL4, SDH}, MDH2 (malate dehydrogenase 2) [NCBI Gene 4191] {aka DEE51, EIEE51, M-MDH, MDH, MGC:3559, MOR1}, ACADS (acyl-CoA dehydrogenase short chain) [NCBI Gene 35] {aka ACAD3, SCAD}, ACAD9 (acyl-CoA dehydrogenase family member 9) [NCBI Gene 28976] {aka MC1DN20, NPD002}, INHCAP (inhibitor of carbonic anhydrase pseudogene) [NCBI Gene 100129696] {aka TFP, TFP1}, ETFDH (electron transfer flavoprotein dehydrogenase) [NCBI Gene 2110] {aka ETFQO, MADD}, CS (citrate synthase) [NCBI Gene 1431], CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}
- **Diseases:** MAS (MESH:C564973), injury to (MESH:D014947), ischemia (MESH:D007511), hypoxia (MESH:D000860)
- **Chemicals:** MOPS (MESH:C008550), fatty acyl-CoAs (MESH:D000214), OAA (MESH:D062907), aspartate (MESH:D001224), amino acids (MESH:D000596), NADP (MESH:D009249), urea (MESH:D014508), acyl-carnitines (MESH:C116917), FAD (MESH:D005182), CoA (MESH:D003065), octanoyl-carnitine (MESH:C008698), Carbohydrates (MESH:D002241), Fatty Acids (MESH:D005227), P-C (MESH:C053518), superoxide (MESH:D013481), 2H2O (-), proton (MESH:D011522), palmitoyl carnitine (MESH:D010172), alpha-KG (MESH:D007656), unsaturated fatty acids (MESH:D005231), malonate (MESH:C030290), sodium (MESH:D012964), carnitine (MESH:D002331), NAD (MESH:D009243), KCl (MESH:D011189), H+ (MESH:D006859), Glucose (MESH:D005947), ubiquinol (MESH:C003741), calcium (MESH:D002118), FA (MESH:D005492), FADH2 (MESH:C058805), ATP (MESH:D000255), fructose (MESH:D005632), Q (MESH:D005973), FMN (MESH:D005486), citrate (MESH:D019343), rotenone (MESH:D012402), EGTA (MESH:D004533), CO2 (MESH:D002245), lipid (MESH:D008055), CoQ (MESH:D014451), ammonium (MESH:D064751), isocitrate (MESH:C034219), Lactate (MESH:D019344), CCCP (MESH:D002258), prostaglandins (MESH:D011453), ADP (MESH:D000244), triglycerides (MESH:D014280), Alanine (MESH:D000409), TCA (MESH:D014233), carbon (MESH:D002244), Succinate (MESH:D019802), MgCl2 (MESH:D015636), Pyruvate (MESH:D019289), ketoacids (MESH:D007651), NaCl (MESH:D012965), mannose (MESH:D008358), sugars (MESH:D000073893), Oxygen (MESH:D010100), zinc (MESH:D015032)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** aspartate for glutamate

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12939201/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939201/full.md

## References

74 references — full list in the complete paper: https://tomesphere.com/paper/PMC12939201/full.md

---
Source: https://tomesphere.com/paper/PMC12939201